NR2F1 and mTORC1 provide the bridge between melanoma dormancy and therapeutic resistance. Mamidi N, Das SK, Fisher PB. J Clin Invest 2025;135:e197764.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Mamidi N, Das SK, Fisher PB. NR2F1 and mTORC1 provide the bridge between melanoma dormancy and therapeutic resistance. J Clin Invest 2025;135:e197764.
PMID: 40955667